• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Introduction to Ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate (CAS No. 1531188-96-1)

Ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate, identified by the chemical compound code CAS No. 1531188-96-1, is a significant compound in the field of pharmaceutical chemistry. This compound belongs to the benzodiazole class, which is well-known for its diverse biological activities and applications in medicinal chemistry. The benzodiazole core structure is characterized by a benzene ring fused with a diazepine ring, making it a versatile scaffold for drug development.

The< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate molecule exhibits potential pharmacological properties due to the presence of both amino and carboxylate functional groups. These functional groups contribute to its reactivity and interaction with biological targets, making it a valuable intermediate in the synthesis of more complex pharmaceutical agents. The< strong>CAS No. 1531188-96-1 uniquely identifies this compound in scientific literature and databases, facilitating its study and application in research.

In recent years, there has been growing interest in benzodiazole derivatives due to their therapeutic potential. Research has highlighted the< strong>2-amino-1H-1,3-benzodiazole-4-carboxylate moiety as a promising scaffold for developing new drugs targeting neurological and inflammatory disorders. The ethyl ester group in< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate adds an additional layer of functionality, allowing for further chemical modifications and derivatization to enhance specific pharmacological effects.

One of the most compelling aspects of< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate is its role in the synthesis of novel therapeutic agents. For instance, studies have demonstrated its utility in creating compounds with potential anti-inflammatory and analgesic properties. The< strong>CAS No. 1531188-96-1-tagged compound has been used as a building block in multi-step synthetic routes to develop molecules that interact with specific enzymes and receptors involved in pain signaling pathways.

The pharmacological activity of benzodiazole derivatives is often linked to their ability to modulate neurotransmitter systems. In particular, the< strong>2-amino group in< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate can participate in hydrogen bonding interactions with biological targets, influencing drug efficacy and selectivity. Additionally, the< strong>carboxylate group provides a site for further functionalization, enabling the design of derivatives with tailored pharmacokinetic profiles.

In academic research,< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate has been employed in various experimental setups to explore new drug candidates. For example, it has been used as a precursor in the synthesis of compounds targeting GABA receptors, which are crucial for anxiety and seizure disorders. The versatility of this compound makes it an attractive choice for medicinal chemists seeking to develop innovative treatments for neurological conditions.

The synthesis of< strong>CAS No. 1531188-96-1-labeled compounds often involves sophisticated organic reactions that highlight the expertise of researchers in pharmaceutical chemistry. Techniques such as nucleophilic substitution reactions and condensation processes are commonly employed to construct the benzodiazole core structure efficiently. These synthetic strategies ensure high yields and purity, which are essential for subsequent pharmacological evaluations.

The growing body of literature on benzodiazole derivatives underscores their importance in modern drug discovery. Researchers continue to explore new ways to leverage the< strong>2-amino group,< strong>carboxylate group, and other functional aspects of compounds like< strong>ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate. This ongoing research not only expands our understanding of these molecules but also paves the way for novel therapeutic interventions across various medical disciplines.

In conclusion,< strong>Ethyl 2-amino-1H-1,3-benzodiazole-4-carboxylate (CAS No. 1531188-96-1) represents a significant advancement in pharmaceutical chemistry due to its structural features and potential biological activities. Its role as a versatile intermediate and building block for drug development underscores its importance in both academic research and industrial applications. As scientific exploration continues, we can expect further discoveries that highlight the therapeutic potential of this remarkable compound.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)